Transcriptomics

Dataset Information

0

Gfi1b - A key player in genesis and maintenance of AML and MDS [expression microarray]


ABSTRACT: Differentiation of hematopoietic stem cells (HSCs) is regulated by a concert of different transcription factors (TFs). A disturbed function of TFs can be the basis of (pre)malignancies such as myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). Growth Factor Independence 1b (Gfi1b) is a repressing TF with a key role in quiescence of HSCs and emergence and maturation of erythrocytes and platelets. Here, we show that low expression of GFI1B in blast cells is associated with inferior prognosis of MDS and AML patients. Using mouse models with either reduced expression or conditional deletion of Gfi1b, crossed with a mouse model reflecting human MDS or AML, we demonstrate that AML development was accelerated with heterozygous loss of Gfi1b, and latency was further decreased when Gfi1b was conditionally deleted. Loss of Gfi1b significantly enhanced stemness of leukemic cells with upregulation of genes fundamentally involved in leukemia development. On a molecular level, we found that loss of Gfi1b not only increased the levels of reactive oxygen species (ROS) but also induced gene expression changes of key AML pathways such as the p38/AKT pathway. These results demonstrate that Gfi1b functions as an oncosuppressor in MDS/AML development. We used microarrays to detail the effect of loss of Gfi1b expression on key AML-pathways in a mouse model system

ORGANISM(S): Mus musculus

PROVIDER: GSE88882 | GEO | 2018/03/31

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2018-03-31 | GSE88934 | GEO
| PRJNA349146 | ENA
2017-09-01 | GSE85737 | GEO
2019-02-21 | GSE117944 | GEO
2010-09-03 | E-GEOD-20655 | biostudies-arrayexpress
2019-09-30 | GSE133828 | GEO
2019-09-30 | GSE133680 | GEO
2019-09-30 | GSE133679 | GEO
2020-03-09 | GSE146598 | GEO
| PRJNA349018 | ENA